There is one clinical trial.
To assess the seroprevalence of SARS-CoV-2 IgG in Health care workers in three University Hospitals
Description: health care workers who have positive IGg in seumMeasure: Number of IGg seropositive health care workers Time: single measurement from each person collected over 2 months
Description: to know positive IGg persons and IGg negative persons to understand risk factorsMeasure: Differentiation between low risk and high risk HCWs Time: 2 months through out duration of study
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports